Meng XY - Search Results

1

[Analysis of the factors affecting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients].

Sun B, Song ST, Jiang ZF, Wang T, Zhang SH, Meng XY, Li XB, Yu CZ, Wu SK. Sun B, et al. Among authors: meng xy. Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):38-42. doi: 10.3760/cma.j.issn.0253-3766.2013.01.008. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23648298 Chinese.

2

[Establish and analyze the predictive model of early stage brain metastases in patients with breast cancer].

Wang Q, Wu S, Sun B, Huang Z, Meng X, Huang Y. Wang Q, et al. Zhonghua Yi Xue Za Zhi. 2015 Dec 19;95(48):3927-9. doi: 10.3760/cma.j.issn.0376-2491.2015.48.012. Zhonghua Yi Xue Za Zhi. 2015. PMID: 27122216 Chinese.

3

Sunitinib as salvage treatment including potent anti-tumor activity in carcinomatous ulcers for patients with multidrug-resistant metastatic breast cancer.

Sun B, Zhao X, Ding L, Meng X, Song S, Wu S. Sun B, et al. Oncotarget. 2016 Sep 6;7(36):57894-57902. doi: 10.18632/oncotarget.11082. Oncotarget. 2016. PMID: 27506945 Free PMC article.

4

Receptor conversion in metastatic breast cancer: a prognosticator of survival.

Meng X, Song S, Jiang ZF, Sun B, Wang T, Zhang Sh, Wu Sh. Meng X, et al. Oncotarget. 2016 Nov 1;7(44):71887-71903. doi: 10.18632/oncotarget.12114. Oncotarget. 2016. PMID: 27655689 Free PMC article.

5

[A clinical study of reasonable doses of docetaxel salvage therapy for patients with metastatic breast cancer].

Wu SK, Ma Y, Meng XY, Sun B, Wang T, Zhang SH, Jiang ZF, Song ST. Wu SK, et al. Among authors: meng xy. Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):764-9. doi: 10.3760/cma.j.issn.0253-3766.2012.10.010. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23291071 Chinese.

6

[Analysis of chemotherapeutic efficacies in metastatic triple-negative breast cancer].

Wu SK, Zhao X, Meng XY, DU M, Zhang SH, Wang T, Song ST, Jiang ZF. Wu SK, et al. Among authors: meng xy. Zhonghua Yi Xue Za Zhi. 2012 Nov 13;92(42):3001-3. doi: 10.3760/cma.j.issn.0376-2491.2012.42.014. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23328295 Chinese.

7

[Clinical observation of sunitinib treatment for refractory advanced breast cancer ulcer].

Zhao X, Meng XY, Sun B, Ding LJ, Jiang ZF, Song ST, Wu SK. Zhao X, et al. Among authors: meng xy. Zhonghua Yi Xue Za Zhi. 2013 Jan 8;93(2):96-8. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23648343 Chinese.

8

Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer.

Sun B, Huang Z, Wu S, Shen G, Cha L, Meng X, Ding L, Wang J, Song S. Sun B, et al. Radiother Oncol. 2016 Jan;118(1):181-6. doi: 10.1016/j.radonc.2015.11.010. Epub 2015 Dec 7. Radiother Oncol. 2016. PMID: 26674923

9

Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report.

Sun B, Ding L, Wu S, Meng X, Song S. Sun B, et al. Onco Targets Ther. 2016 Jul 1;9:3997-4003. doi: 10.2147/OTT.S104398. eCollection 2016. Onco Targets Ther. 2016. PMID: 27445490 Free PMC article.

10

Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer.

Liu C, Huang Z, Wang Q, Sun B, Ding L, Meng X, Wu S. Liu C, et al. Onco Targets Ther. 2016 Jul 27;9:4653-60. doi: 10.2147/OTT.S106017. eCollection 2016. Onco Targets Ther. 2016. PMID: 27536129 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters